Skip to main content
Premium Trial:

Request an Annual Quote

Galapagos Genomics Identifies Several Drug Targets

NEW YORK, June 7 (GenomeWeb News) - Galapagos Genomics said today that it has identified, validated, and filed patent applications for several novel drug targets in Alzheimer's disease, osteoporosis, osteoarthritis, rheumatoid arthritis, and asthma.


Galapagos identified the targets using its FlexSelect adenoviral-based over-expression and SilenceSelect siRNA gene knockdown technologies.


"We are very pleased to see that our target discovery engine in combination with our disease biology expertise has delivered an exiting set of proprietary targets that are ready to be taken into small molecule screening," Onno van de Stolpe, CEO of Galapagos, said in a statement.


The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.